Types of Cancer We Treat

Colorectal Cancer

Our medical, surgical, and radiation oncologists, gastroenterologists, and radiologists provide comprehensive, coordinated treatment and seamless care for people with even the most complex colorectal cancers, all under one roof. We personalize your treatment plan based on the location of the tumor, how advanced it is, and its molecular and genetic features.

Our clinical trials provide new and promising treatment options for people with early and more advanced colorectal cancer. NYU Langone doctors also offer high-quality colon cancer screening at convenient locations throughout the New York City area.

Meet Our Doctors
Dr. H. Leon Pachter
Our Approach to Colorectal Cancer Treatment Our Approach to Colorectal Cancer Treatment
Diagnosis
Colorectal Cancer Diagnosis
Preventive Treatment
Colorectal Cancer Preventive Treatment
Surgery
Colorectal Cancer Surgery
Chemotherapy
Colorectal Cancer Chemotherapy
Immunotherapy & Targeted Therapies
Colorectal Cancer Immunotherapy and Targeted Therapies
Radiation Therapy
Colorectal Cancer Radiation Therapy

Related News

Barbershop Outreach Helps to Prevent Colorectal Cancer
Read Story
More Awareness of Colorectal Cancer Needed in Young Adults
Read Story

Clinical Trials and Research Studies

Phase 3

Randomized Trial of Standard Chemotherapy Alone or Combined with Atezolizumab as Adjuvant Therapy for Patients with Stage III Colon Cancer and Deficient DNA Mismatch Repair

Learn More

Phase 3

Colorectal Cancer Metastatic MSI-High Immuno-Therapy (COMMIT) Study: A Randomized Phase III Study of mFOLFOX6/Bevacizumab Combination Chemotherapy with or without Atezolizumab or Atezolizumab Monotherapy in the First-Line Treatment of Patients with Micros

Learn More

Phase 1

Phase 1b Open-label Study of MK-7162 in Combination with Pembrolizumab (MK-3475) +/- other therapies in Participants with Advanced Solid Tumors

Learn More

Phase 1/2

A PHASE 1B/2 OPEN-LABEL STUDY TO EVALUATE SAFETY CLINICAL ACTIVITY PHARMACOKINETICS AND PHARMACODYNAMICS OF AVELUMAB (MSB0010718C) IN COMBINATION WITH OTHER CANCER IMMUNOTHERAPIES IN PATIENTS WITH ADVANCED MALIGNANCIES

Learn More
View All Related Clinical Trials (7)